Sunstar Kabushiki Kaisha

501 Sunstar Kabushiki Kaisha

502 Toray Industries, Inc.

Sunstar Suisse S.a.

Yasuhiro Katsuragi

Kunio Sugihara

Yasuo Sakano

Kenji Aimoto

Mitsunobu Sato

Kenji Hasegawa

Toshio Satoh

Masakazu Nakamura

Kazuyoshi Kita

Akane Takemura

Yasunobu Kobayashi

Yoshiko Saiga

Naoki Matsuda

Hiromu Kato

Kunio Nishimoto

Kunio; Nishimoto

A pharmaceutical or veterinary composition for activating the function of phygocytes comprising as an effective ingredient a certain tocopheryl glycoside. The composition is useful for treating infectious diseases and malignant tumor.

Composition for activating function of phagocytes

A pharmaceutical composition for treating viral diseases, such as pasta, gargle, gel, ointment, suppository, spray, etc., containing interferon in a stable state which comprises an effective amount of human interferon, 15 to 60% by weight of a tri or higher polyhydric sugar alcohol and an organic acid buffer as stabilizers, and a conventional pharmaceutical carrier or diluent. The pH of the composition is about 3 to 6. Optionally, the composition can further contain as a stabilizer an anionic surfactant and/or albumin.

Pharmaceutical composition containing interferon in stable state

A pharmaceutical composition for treating erythematodes, particularly, lupus erythematodes discoides, or mycosis, particularly, candidasis, by topical or local administration which comprises an effective amount of human interferon, a trihydric or more higher polyhydric sugar alcohol, an organic acid buffer and, optionally, an anionic surfactant and albumin, and a conventional pharmaceutical carrier or diluent. A method for treating a human subject suffering from erythematodes and mycosis by using this composition is also provided.

Composition and method for treating erythematodes and mycosis

A pharmaceutical composition for treating keratosic disorders of skin and mucosa, particularly, lichen planus and leukoplakia, by topical or local administration which comprises an effective amount of human interferon, a trihydric or more higher polyhydric sugar alcohol, an organic acid buffer and, optionally, an anionic surfactant and albumin, and a conventional pharmaceutical carrier or diluent. A method for treating a human subject suffering from keratosic disorders of skin and mucosa by using this composition is also provided.

Composition and method for treating keratosic disorder of skin and mucosa

Growing community of inventors

Toyonaka, Japan

Yasuhiro Katsuragi